# Therasphere® for Treatment of Unresectable Primary Liver Cancer and Metastatic Liver Cancer

> **NCT00701168** · — · NO_LONGER_AVAILABLE · sponsor: **Leo W. Jenkins Cancer Center**

## Conditions studied

- Carcinoma, Hepatocellular
- Neoplasm Metastasis

## Interventions

- **DEVICE:** yttrium Y 90 microspheres (Therasphere®)

## Key facts

- **NCT ID:** NCT00701168
- **Lead sponsor:** Leo W. Jenkins Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2017-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00701168

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00701168, "Therasphere® for Treatment of Unresectable Primary Liver Cancer and Metastatic Liver Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00701168. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*